Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin-Bound Paclitaxel and Nedaplatin via Hepatic Arterial Infusion for Breast Cancer Liver Metastases
NCT07284836Phase 2Recruiting
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Feb 2025
- Primary completion
- Jan 2028
- Modality
- Polymer-based Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel, nedaplatin in breast cancer, sponsored by Zhejiang Cancer Hospital. Started Feb 2025; status: recruiting.
02
Drugs
nab-paclitaxelnedaplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07284836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07284836.